Oxygen for the delivery room respiratory support of moderate‐to‐late preterm infants. An international survey of clinical practice from 21 countries

Aim The aim of this study was to determine clinician opinion regarding oxygen management in moderate‐late preterm resuscitation. Methods An anonymous online questionnaire was distributed through email/social messaging platforms to neonatologists in 21 countries (October 2020‐March 2021) via REDCap....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta Paediatrica 2021-12, Vol.110 (12), p.3261-3268
Hauptverfasser: Sotiropoulos, James X., Kapadia, Vishal, Vento, Maximo, Rabi, Yacov, Saugstad, Ola D., Kumar, R. Kishore, Schmölzer, Georg M., Zhang, Huyan, Yuan, Yuan, Lim, Gina, Kusuda, Satoshi, Arimitsu, Takeshi, Nguyen, Tinh Thu, Kitsommart, Ratchada, Yeo, Kee Thai, Oei, Ju Lee
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim The aim of this study was to determine clinician opinion regarding oxygen management in moderate‐late preterm resuscitation. Methods An anonymous online questionnaire was distributed through email/social messaging platforms to neonatologists in 21 countries (October 2020‐March 2021) via REDCap. Results Of the 695 respondents, 69% had access to oxygen blenders and 90% had pulse oximeters. Respondents from high‐income countries were more likely to have oxygen blenders than those from middle‐income countries (72% vs. 66%). Most initiated respiratory support with FiO2 0.21 (43%) or 0.3 (36%) but only 45% titrated FiO2 to target SpO2. Most (89%) considered heart rate as a more important indicator of response than SpO2. Almost all (96%) supported the need for well‐designed trials to examine oxygenation in moderate‐late preterm resuscitation. Conclusion Most clinicians resuscitated moderate‐late preterm infants with lower initial FiO2 but some cannot/will not target SpO2 or titrate FiO2. Most consider heart rate as a more important indicator of infant response than SpO2.Large and robust clinical trials examining oxygen use for moderate‐late preterm resuscitation, including long‐term neurodevelopmental outcomes, are supported amongst clinicians.
ISSN:0803-5253
1651-2227
DOI:10.1111/apa.16091